Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma
Start Date
9/8/2023
Completion Date
9/1/2026
Summary
The researchers are doing this study to test the ability of a new technology called breathprinting, or electronic nose (E-Nose), to measure how people respond to standard treatment for malignant pleural mesothelioma (MPM). The researchers will study how E-Nose breathprints change over time as people receive standard treatment for MPM. They will also look at how changes in people's E-Nose breathprints compare to changes in their standard imaging scans and in biomarkers of MPM in their blood.
Eligibility Criteria
Age Range: 30 years to 85 years
Interventions
E-Nose testing
Research blood
Conditions
Locations
Memorial Sloan Kettering Basking Ridge (Consent Only)
Basking Ridge, New Jersey 07920
United States
Memorial Sloan Kettering Monmouth (Consent Only)
Middletown, New Jersey 07748
United States
Memorial Sloan Kettering Bergen (Consent Only )
Montvale, New Jersey 07645
United States
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent Only)
Commack, New York 11725
United States
Memorial Sloan Kettering Westchester (Consent Only)
Harrison, New York 10604
United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York 10065
United States
Memorial Sloan Kettering Nassau (Consent Only)
Uniondale, New York 11553
United States